ObsEva (NASDAQ:OBSV) Coverage Initiated by Analysts at StockNews.com

StockNews.com initiated coverage on shares of ObsEva (NASDAQ:OBSV) in a report released on Sunday morning. The brokerage issued a hold rating on the stock.

ObsEva Stock Down 15.5 %

OBSV stock opened at $0.10 on Friday. ObsEva has a one year low of $0.08 and a one year high of $2.14. The stock has a market capitalization of $7.94 million, a price-to-earnings ratio of -0.11 and a beta of 0.68. The firm’s 50-day moving average price is $0.01.

About ObsEva

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.